It can be concluded that simultaneous attack of BET and FGFR1 proteins may inhibit the mechanisms of intrinsic resistance and have a beneficial effect on inhibiting GBM cell proliferation in clinical settings [267]. The gene discussed is FGFR1; the disease is glioblastoma.